“…Previous studies demonstrated enhanced lipid peroxidation and malondialdehyde in patients with OSCC. The included studies had found a statistically significant increase in plasma or serum MDA levels in OSCC patients compared with controls (p < 0.001) [8,12,[19][20][21][22]24,30,32,[35][36][37]39,40,43,46,47,49,65]. Similarly, other studies also observed a significant rise compared with the control group (p < 0.05) [8,17,25,31,34,44,52,53,67].…”